Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – Long-term ambrisentan therapy safely improves exercise capacity in patients with pulmonary arterial hypertension (PAH), according to results of an extension protocol that followed…
NEW YORK (Reuters Health) – In patients with locoregionally advanced squamous-cell carcinoma of the head and neck (LASCCHN), the survival benefit of adding cetuximab to radiotherapy is still…
NEW YORK (Reuters Health) – The bone anabolic drug teriparatide is more effective than alendronate at increasing bone mineral density (BMD) and preventing vertebral fractures in patients with…
NEW YORK (Reuters Health) – In kidney transplant recipients, bringing hemoglobin levels above 125 g/L with erythropoietin may increase mortality, according to a report in the November 6th…
NEW YORK (Reuters Health) – Monofilament testing alone is inadequate for diagnosing peripheral neuropathy, according to a systematic literature review done by physicians in The Netherlands. As the…
NEW YORK (Reuters Health) – New research suggests that extracorporeal shock-wave therapy (ESWT) is a viable alternative to surgery for long-bone hypertrophic nonunions. “When we examined patients and…
NEW YORK (Reuters Health) – Exercise-induced ST-segment elevation in patients who never had a myocardial infarction (MI) is a highly specific marker of coronary artery disease and a…
A controversial audit program in the process of being rolled out in all 50 states by 2010 is sparking concerns not just from the nation’s largest hospitals, but…
NEW YORK (Reuters Health) – More than half of women in a recent survey had undiagnosed urinary incontinence, with two thirds reporting moderate to severe symptoms. Because urinary…
NEW YORK (Reuters Health) – Blood transfusion is safe and may be beneficial in patients with acute decompensated heart failure, say researchers from Israel in the October American…
